| Year |
Citation |
Score |
| 2019 |
Ravi D, Sarkar S, Purvey S, Passero F, Beheshti A, Chen Y, Mokhtar M, David K, Konry T, Evens AM. Interaction kinetics with transcriptomic and secretory responses of CD19-CAR natural killer-cell therapy in CD20 resistant non-hodgkin lymphoma. Leukemia. PMID 31772298 DOI: 10.1038/S41375-019-0663-X |
0.318 |
|
| 2019 |
Passero FC, Ravi D, McDonald JT, Beheshti A, David KA, Evens AM. Combinatorial ixazomib and belinostat therapy induces NFE2L2-dependent apoptosis in Hodgkin and T-cell lymphoma. British Journal of Haematology. PMID 31452195 DOI: 10.1111/Bjh.16160 |
0.356 |
|
| 2019 |
Beheshti A, McDonald JT, Miller J, Grabham P, Costes SV. GeneLab Database Analyses Suggest Long-Term Impact of Space Radiation on the Cardiovascular System by the Activation of Through Reactive Oxygen Species. International Journal of Molecular Sciences. 20. PMID 30717456 DOI: 10.3390/Ijms20030661 |
0.301 |
|
| 2019 |
Dashnamoorthy R, Sarkar S, Beheshti A, Mokhtar M, Konry T, Levin M, Evens AM. Transcriptomic and Metabolomic Profiling Identifies Calcium-Dependent Signaling Mechanisms As a Novel and Exploitable Target to Overcome Anti-CD20 Resistance in Non-Hodgkin Lymphoma (NHL) Blood. 134: 1511-1511. DOI: 10.1182/Blood-2019-126539 |
0.331 |
|
| 2019 |
Dashnamoorthy R, Beheshti A, Su X, Chen Y, Mokhtar M, Dolnikowski G, Lansigan F, Kinlaw WB, Dave S, Evens AM. Identification of FASN-Dependent Onco-Metabolic Regulation of the Pentose Phosphate Pathway (PPP) and Nucleotide Metabolism in Non-Hodgkin Lymphoma (NHL) Blood. 134: 1573-1573. DOI: 10.1182/Blood-2019-126382 |
0.357 |
|
| 2018 |
Cortese F, Klokov D, Osipov A, Stefaniak J, Moskalev A, Schastnaya J, Cantor C, Aliper A, Mamoshina P, Ushakov I, Sapetsky A, Vanhaelen Q, Alchinova I, Karganov M, Kovalchuk O, ... ... Beheshti A, et al. Vive la radiorésistance!: converging research in radiobiology and biogerontology to enhance human radioresistance for deep space exploration and colonization. Oncotarget. 9: 14692-14722. PMID 29581875 DOI: 10.18632/Oncotarget.24461 |
0.301 |
|
| 2018 |
Kapadia B, Nanaji NM, Bhalla K, Bhandary B, Lapidus R, Beheshti A, Evens AM, Gartenhaus RB. Fatty Acid Synthase induced S6Kinase facilitates USP11-eIF4B complex formation for sustained oncogenic translation in DLBCL. Nature Communications. 9: 829. PMID 29483509 DOI: 10.1038/S41467-018-03028-Y |
0.302 |
|
| 2018 |
Bhalla K, Jaber S, Nahid M N, Underwood K, Beheshti A, Landon A, Bhandary B, Bastain P, Evens AM, Haley J, Polster B, Gartenhaus RB. Role of hypoxia in Diffuse Large B-cell Lymphoma: Metabolic repression and selective translation of HK2 facilitates development of DLBCL. Scientific Reports. 8: 744. PMID 29335581 DOI: 10.1038/S41598-018-19182-8 |
0.334 |
|
| 2018 |
Dashnamoorthy R, Beheshti A, Sarkar S, Konry T, Levin M, Evens AM. Systems Biology Analyses to Delineate Mechanisms of Anti-CD20 Antibody Resistance in Non-Hodgkin Lymphoma (NHL): Influence of BCR Signaling and the Critical Importance of Calcium Polarization Blood. 132: 1665-1665. DOI: 10.1182/Blood-2018-99-118787 |
0.315 |
|
| 2018 |
Dashnamoorthy R, Beheshti A, Cass S, Kritharis A, Burgess K, London C, Evens AM. Transcriptomic Systems Biology Analyses with Buparlisib (BKM120) Pan PI3K Inhibition in Canine B Cell Lymphoma (BCL): Leveraging Comparative Oncology for Cancer Therapeutics and Biomarker Discovery Blood. 132: 4114-4114. DOI: 10.1182/Blood-2018-99-118548 |
0.372 |
|
| 2017 |
Sarkar S, Sabhachandani P, Ravi D, Potdar S, Purvey S, Beheshti A, Evens AM, Konry T. Dynamic Analysis of Human Natural Killer Cell Response at Single-Cell Resolution in B-Cell Non-Hodgkin Lymphoma. Frontiers in Immunology. 8: 1736. PMID 29312292 DOI: 10.3389/Fimmu.2017.01736 |
0.344 |
|
| 2017 |
Dashnamoorthy R, Chen B, Galera P, Chang H, Beheshti A, Ghosh S, Evens AM. The Immune Checkpoint Receptors PD-1, PD-L1, TIM-3 and LAG-3 in Lymphoma: Tumor Cell and Tumor Infiltrating Lymphocyte (TIL) Expression, Patient Prognostication, and Identification of Rational Therapeutic Targets Blood. 130: 2750-2750. DOI: 10.1182/Blood.V130.Suppl_1.2750.2750 |
0.351 |
|
| 2017 |
Purvey S, Dashnamoorthy R, Beheshti A, Klein A, Boissel L, Sarkar S, Konry T, Evens AM. CD19-Chimeric Antigen Receptor (CAR) Engineered Natural Killer (NK) Cell Therapy: Novel Off the Shelf Immunotherapy in CD20 Resistant B-Cell Non-Hodgkin Lymphoma (NHL) Cell Lines, Primary NHL Cells, and a Human Lymphoma Xenograft Model Blood. 130: 110-110. DOI: 10.1182/Blood.V130.Suppl_1.110.110 |
0.343 |
|
| 2016 |
Ravi D, Beheshti A, Abermil N, Passero F, Sharma J, Coyle M, Kritharis A, Kandela I, Hlatky L, Sitkovsky MV, Mazar AP, Gartenhaus RB, Evens AM. Proteasomal Inhibition by Ixazomib Induces CHK1 and MYC Dependent Cell Death in T-Cell and Hodgkin Lymphoma. Cancer Research. PMID 26988986 DOI: 10.1158/0008-5472.Can-15-2477 |
0.384 |
|
| 2016 |
Dashnamoorthy R, Beheshti A, Sarkar S, Sabhachandani P, Passero FC, Purvey S, Boissel L, Konry T, Evens AM. CD19 Target Activated Natural Killer (CD19.TaNK) Cellular Therapy: A Novel immunotherapeutic Approach to the Treatment of Non-Hodgkin Lymphoma (NHL) Blood. 128: 4174-4174. DOI: 10.1182/Blood.V128.22.4174.4174 |
0.33 |
|
| 2016 |
Passero FC, Dashnamoorthy R, Beheshti A, McDonald JT, Evens AM. Proteasome and HDAC Inhibitor Therapy in T-Cell Lymphoma (TCL) and Hodgkin Lymphoma (HL): Nuclear Factor Erythroid 2 like 2 (NRF2)-Dependent Cell Death and Function Blood. 128: 3020-3020. DOI: 10.1182/Blood.V128.22.3020.3020 |
0.356 |
|
| 2016 |
Beheshti A, Coyle ME, Dashnamoorthy R, Evens AM. Buparlisib/BKM120 PI3 Kinase Therapy in B Cell and T Cell Non-Hodgkin Lymphoma (NHL) and Hodgkin Lymphoma (HL): Identification of Resistance Pathways and Biomarker Discovery Blood. 128: 2920-2920. DOI: 10.1182/Blood.V128.22.2920.2920 |
0.415 |
|
| 2015 |
Beheshti A, Neuberg D, McDonald JT, Vanderburg CR, Evens AM. The Impact of Age and Sex in DLBCL: Systems Biology Analyses Identify Distinct Molecular Changes and Signaling Networks. Cancer Informatics. 14: 141-8. PMID 26691437 DOI: 10.4137/Cin.S34144 |
0.323 |
|
| 2015 |
Beheshti A, Wage J, McDonald JT, Lamont C, Peluso M, Hahnfeldt P, Hlatky L. Tumor-host signaling interaction reveals a systemic, age-dependent splenic immune influence on tumor development. Oncotarget. PMID 26497558 DOI: 10.18632/Oncotarget.6214 |
0.328 |
|
| 2015 |
Wage J, Ma L, Peluso M, Lamont C, Evens AM, Hahnfeldt P, Hlatky L, Beheshti A. Proton irradiation impacts age-driven modulations of cancer progression influenced by immune system transcriptome modifications from splenic tissue. Journal of Radiation Research. PMID 26253138 DOI: 10.1093/Jrr/Rrv043 |
0.34 |
|
| 2015 |
Beheshti A, Benzekry S, McDonald JT, Ma L, Peluso M, Hahnfeldt P, Hlatky L. Host age is a systemic regulator of gene expression impacting cancer progression. Cancer Research. 75: 1134-43. PMID 25732382 DOI: 10.1158/0008-5472.Can-14-1053 |
0.326 |
|
| 2015 |
Kritharis A, McDonald JT, Beheshti A, Pilichowska M, Burgess K, Ricks-Santi L, McNiel E, Dashnamoorthy R, Evens AM. A Comparative Oncology Analysis of Canine T-Cell Lymphoma (TCL): Immunohistochemical Study and Next Generation Sequencing for Protein Analysis and Genomic Target Discovery Blood. 126: 3883-3883. DOI: 10.1182/Blood.V126.23.3883.3883 |
0.33 |
|
| 2015 |
Passero FC, Dashnamoorthy R, Beheshti A, Hlatky L, Abermil N, Coyle ME, Sharma J, Evens AM. The Proteasome Inhibitor, Ixazomib, Combined with Novel Drug Combinations in T-Cell Lymphoma (TCL) and Hodgkin Lymphoma (HL): Identification of Key Genes and Signaling Pathways Via a Novel Systems Biology Approach Blood. 126: 2753-2753. DOI: 10.1182/Blood.V126.23.2753.2753 |
0.381 |
|
| 2015 |
Beheshti A, Neuberg DS, McDonald JT, Evens AM. The Impact of Age and Sex in DLBCL: Determination of Biologic Dynamics and Delineation of Inter-Connected Signaling Networks Via a Systems Biology Analysis Blood. 126: 2672-2672. DOI: 10.1182/Blood.V126.23.2672.2672 |
0.353 |
|
| 2015 |
Coyle ME, Dashnamoorthy R, Beheshti A, Evens AM. The PI3 Kinase (PI3K) Inhibitor, Buparlisib/BKM120, in B-Cell, T-Cell and Hodgkin Lymphoma Cell Lines: Cell Death Studies and Examination of Genomic Pathway Analyses Via a Systems Biology Approach Blood. 126: 1555-1555. DOI: 10.1182/Blood.V126.23.1555.1555 |
0.371 |
|
| 2015 |
Dashnamoorthy R, Beheshti A, Abermil N, Lansigan F, Kinlaw W, Gartenhaus R, Jones G, Hlatky L, Evens AM. Lipid Addiction of Diffuse Large B-Cell Lymphoma (DLBCL): Fatty Acid Synthase (FASN) and PI3K Dependent Cell Death Identifies a Novel Therapeutic Paradigm Blood. 126: 1284-1284. DOI: 10.1182/Blood.V126.23.1284.1284 |
0.405 |
|
| 2014 |
Beheshti A, Peluso M, Lamont C, Hahnfeldt P, Hlatky L. Proton irradiation augments the suppression of tumor progression observed with advanced age. Radiation Research. 181: 272-83. PMID 24568128 DOI: 10.1667/Rr13538.1 |
0.339 |
|
| 2014 |
Kritharis A, Fowler T, Dashnamoorthy R, Burgess KE, Beheshti A, Abermil N, Roy A, Hlatky L, Pilichowska M, McNiel E, Evens AM. A Comparative Oncology Study of Canine and Human Genomics and Proteomics in Peripheral T-Cell Lymphoma (PTCL): Examination of Shared Oncogenic Signaling for Biomarker and Therapeutic Target Discovery Blood. 124: 3019-3019. DOI: 10.1182/Blood.V124.21.3019.3019 |
0.365 |
|
| 2013 |
Beheshti A, Sachs RK, Peluso M, Rietman E, Hahnfeldt P, Hlatky L. Age and space irradiation modulate tumor progression: Implications for carcinogenesis risk Radiation Research. 179: 208-220. PMID 23289386 DOI: 10.1667/Rr3100.1 |
0.339 |
|
| 2013 |
Almog N, Ma L, Christine B, Rietman E, Beheshti A, Abdollahi A. Abstract PR13: microRNAs: Master regulators of human tumor dormancy Cancer Research. 73. DOI: 10.1158/1538-7445.Tim2013-Pr13 |
0.333 |
|
| 2012 |
Almog N, Ma L, Schwager C, Brinkmann BG, Beheshti A, Vajkoczy P, Folkman J, Hlatky L, Abdollahi A. Consensus micro RNAs governing the switch of dormant tumors to the fast-growing angiogenic phenotype. Plos One. 7: e44001. PMID 22952847 DOI: 10.1371/Journal.Pone.0044001 |
0.321 |
|
| 2010 |
Girdhani S, Lamont C, Hahnfeldt P, Weremowicz J, Anaya Z, Beheshti A, Abdollahi A, Hlatky L. Abstract 1319: Proton irradiation exerts antiangiogenic and other tumor progression-limiting effects Cancer Research. 70: 1319-1319. DOI: 10.1158/1538-7445.Am10-1319 |
0.337 |
|
| 2009 |
Enderling H, Anderson AR, Chaplain MA, Beheshti A, Hlatky L, Hahnfeldt P. Paradoxical dependencies of tumor dormancy and progression on basic cell kinetics. Cancer Research. 69: 8814-21. PMID 19887613 DOI: 10.1158/0008-5472.Can-09-2115 |
0.351 |
|
| 2002 |
Rill RL, Beheshti A, Van Winkle DH. DNA electrophoresis in agarose gels: effects of field and gel concentration on the exponential dependence of reciprocal mobility on DNA length. Electrophoresis. 23: 2710-9. PMID 12210176 DOI: 10.1002/1522-2683(200208)23:16<2710::Aid-Elps2710>3.0.Co;2-0 |
0.564 |
|
| Show low-probability matches. |